 |
|
|
| |
Retreatment with voxilaprevir/velpatasvir/sofosbuvir in patients with chronic hepatitis C virus infection and prior DAA failure - results from the German Hepatitis C-Registry (DHC-R)
|
| |
| |
Reported by Jules Levin
AASLD 2018 San Francisco Nov 9-13
Johannes Vermehren1*, Albrecht Stoehr2, Julian Schulze zur Wiesch3, Hartwig Klinker4, Markus Cornberg5, Maria-Christina Jung6, Karl-Georg Simon7, Yvonne Serfert8, Michael P. Manns5, Heiner Wedemeyer5,8,9, Christoph Sarrazin1,10, German Hepatitis C-Registry8
1Goethe University Hospital, Medical Clinic 1, Frankfurt, Germany; 2ifi-Institute for Interdisciplinary Medicine, Hamburg, Germany; 3University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; 4University Hospital Würzburg, Würzburg, Germany; 5Hannover Medical School, Hannover, Germany; 6Leberzentrum München, Germany; 7MVZ Dres. Eisenbach, Simon, Schwarz GbR, Leverkusen, Germany; 8Leberstiftungs-GmbH Deutschland, Hannover, Germany; 9Essen University Hospital, University of Duisburg-Essen, Essen, Germany; 10St. Josefs-Hospital, Medical Clinic 2, Wiesbaden, Germany;
|
| |
|
|
|
|
|
